Research Article

Supplemental Bacillus subtilis PB6 Improves Growth Performance and Gut Health in Broilers Challenged with Clostridium perfringens

Table 3

The effect of B. subtilis supplementation on growth performance and mortality in CP-challenged broilers.

Treatment1Control groupCP-challenged model groupAntibiotics
(positive control group)
B. subtilis PB6 low-dosage groupB. subtilis PB6 high-dosage groupSEM2 value3

d1-d18 nonchallenge phase
 BWG (g)36.0635.4735.4435.1435.580.250.86
 FI (g)51.6150.8751.6551.7951.970.440.95
 FCR1.431.441.461.481.460.010.50
 Mortality rate0.000.000.000.000.000.001.00
d19-d26 challenge phase
 BWG (g)66.12a54.95c59.21bc61.62ab62.86ab1.0870.009
 FI (g)109.55a99.90bc98.35c106.30ab108.41a1.3050.007
 FCR1.661.831.671.731.730.020.062
 Mortality rate (%)2.223.491.114.453.580.9070.821
Overall
 BWG (g)46.47a42.21c43.67bc44.31abc45.02ab0.3940.004
 FI (g)71.66a67.84b67.81b70.66ab71.51a0.5440.026
 FCR1.551.611.551.61.590.0090.151
 Mortality rate (%)2.223.491.114.453.580.9070.821

1Treatment information: control group: basal diet; CP-challenged model group: basal diet and CP challenge; antibiotics (positive control group): CP challenge+10 mg/kg enramycin; B. subtilis PB6 low-dosage group: CP challenge+ of feed B. subtilis PB6; B. subtilis PB6 high-dosage group: CP challenge+ of feed B. subtilis PB6. BWG: body weight gain; FI: feed intake; FCR: feed conversion ratio. 2Standard error of the means; chickens/group. 3Mean values within a column with unlike superscripts letters (a, b, and c) are significantly different ().